Correction: Germline alterations among Hispanic men with prostate cancer.

Autor: Pan E; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Shaya J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Madlensky L; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Randall JM; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Javier-Desloges J; Department of Urology, University of California San Diego, La Jolla, CA, USA., Millard FE; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Rose B; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA., Parsons JK; Department of Urology, University of California San Diego, La Jolla, CA, USA., Nielsen SM; Invitae Corporation, San Francisco, CA, USA., Hatchell KE; Invitae Corporation, San Francisco, CA, USA., Esplin ED; Invitae Corporation, San Francisco, CA, USA., Nussbaum RL; Invitae Corporation, San Francisco, CA, USA., Weise N; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Murphy J; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., Martinez ME; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA., McKay RR; Department of Medicine, Division of Hematology-Oncology, University of California San Diego, La Jolla, CA, USA. rmckay@health.ucsd.edu.
Jazyk: angličtina
Zdroj: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Sep; Vol. 25 (3), pp. 599.
DOI: 10.1038/s41391-022-00539-0
Databáze: MEDLINE